Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Kidney360|June 30, 2021
Shaping Up Mitochondria in Diabetic NephropathyKoki Mise, Daniel L Galvan, Farhad R Danesh
Kidney International|September 13, 2017
The hallmarks of mitochondrial dysfunction in chronic kidney diseaseDaniel L Galvan, Nathanael H Green, Farhad R Danesh
Biomacromolecules|March 23, 2011
Injectable multidomain peptide nanofiber hydrogel as a delivery agent for stem cell secretomeErica L Bakota, Yin Wang, Farhad R Danesh, et al.
Diabetes|December 18, 2007
Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose controlVasantha Kolavennu, Lixia Zeng, Hui Peng, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 17, 2016
Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?Mona Doshi, Amit Lahoti, Farhad R Danesh, et al.
The Journal of Biological Chemistry|February 12, 2011
MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathyJianyin Long, Yin Wang, Wenjian Wang, et al.
American Journal of Physiology. Renal Physiology|October 10, 2006
Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetesGianfranco Tramonti, Ping Xie, Elisabeth I Wallner, et al.
The Journal of Biological Chemistry|May 27, 2010
Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditionsJianyin Long, Yin Wang, Wenjian Wang, et al.
Endocrinology|March 17, 2015
FSP-1 Impairs the Function of Endothelium Leading to Failure of Arteriovenous Grafts in Diabetic MiceJinlong Luo, Ming Liang, William E Mitch, et al.
Archivum Immunologiae Et Therapiae Experimentalis|August 5, 2003
Immunomodulatory effects of HMG-CoA reductase inhibitorsFarhad R Danesh, Ramon L Anel, Lixia Zeng, et al.
Pageof 6